Summary
- Current Price
- As of today, PPCB price is $2.37, down -2.47% in the most recent trading session on
- Current Price All-Time High
- PPCB price is currently -100.00% below its historical high of $62,499,999,186,944.00 set on
- Market Cap
- PPCB current market cap is $2M, down -98.65% year-over-year
- Revenue
- PPCB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for PPCB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Propanc Biopharma, Inc. |
| Ticker | NASDAQ: PPCB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | propanc.com |
| Employees | 1 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.37 | ||
| Price, 1D Change | -2.47% | |
| $2M | ||
| - | ||
| - | ||
| 2.75 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$17.62 | ||
| EPS, 1Y Change | +95.25% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$17.62 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $2.37 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.02 | - | |
| - | -$371.22 | - | |
| - | -$17.62 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -99.33% | ||
| -60.17% | ||
| -98.65% | ||
| +100.00% | ||
| 0.00% | ||
| 0.00% | ||
| +95.25% | ||
| -879.58% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.37 | ||
| $25.05 | ||
| $7.28 | ||
| $216.07 | ||
| $6.85 | ||
| -$1.30 | ||
| 2.75 | ||
| $0.07 | ||
| 24.30 | ||
| 122.98% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$17.62 | ||
| -$22.70K | ||
| - | ||
| -$18.19M | ||
| - | ||
| -$18.86M | ||
| - | ||
| -$18.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 2.55 | ||
| 2.55 | ||
| - | ||
| - | ||
| -19.60 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 0.26 | ||
| -0.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $9.40M | ||
| $832.00K | ||
| $12.78M | ||
| $8.54M | ||
| $3.38M | ||
| $3.35M | ||
| $509.10K | ||
| $485.30K | ||
| $1.13M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $18.86M | ||
| $18.16M | ||
| $22.70K | ||
| $670.60K | ||
| $22.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$5.68M | ||
| -$4,900.00 | ||
| $6.46M | ||
| $4,900.00 | ||
| -$5.69M |
Recent analyst updates
No data
Analyst sentiment
No data
Institutional ownership
Screeners with PPCB
FAQ
- What is the ticker symbol for Propanc Biopharma, Inc.?
- The ticker symbol for Propanc Biopharma, Inc. is NASDAQ:PPCB
- Does Propanc Biopharma, Inc. pay dividends?
- No, Propanc Biopharma, Inc. does not pay dividends
- What sector is Propanc Biopharma, Inc. in?
- Propanc Biopharma, Inc. is in the Healthcare sector
- What industry is Propanc Biopharma, Inc. in?
- Propanc Biopharma, Inc. is in the Biotechnology industry
- What country is Propanc Biopharma, Inc. based in?
- Propanc Biopharma, Inc. is headquartered in Australia
- When did Propanc Biopharma, Inc. go public?
- Propanc Biopharma, Inc. initial public offering (IPO) was on November 12, 2012
- Is Propanc Biopharma, Inc. in the S&P 500?
- No, Propanc Biopharma, Inc. is not included in the S&P 500 index
- Is Propanc Biopharma, Inc. in the NASDAQ 100?
- No, Propanc Biopharma, Inc. is not included in the NASDAQ 100 index
- Is Propanc Biopharma, Inc. in the Dow Jones?
- No, Propanc Biopharma, Inc. is not included in the Dow Jones index
- When does Propanc Biopharma, Inc. report earnings?
- The date for Propanc Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- PPCB Official Website www.propanc.com
- PPCB Profile on Yahoo Finance finance.yahoo.com/quote/PPCB
- PPCB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ppcb